Moderna's RSV vaccine shown to provide strong protection against serious cases in adults 50 and older
A single dose of Moderna's mResvia RSV vaccine was 60.3% protective against documented respiratory syncytial virus (RSV) infections, 60.2% against RSV-associated emergency department or urgent care encounters and 81.8% against ...
Nov 12, 2026
0
10









